ModernMedicine - Physician’s Focus

Having trouble viewing this e-mail? Click here

Coinciding with the rise of diabetes in the United States, it is estimated that the number of Americans aged 40 or more years who have diabetic retinopathy will triple from 5.5 million in 2005 to 16.0 million in 2050. ModernMedicine has synthesized intelligence which details the screening technology and research results on management options for patients with diabetes as well as a patient handout.

Covered in the Physician’s Focus:

Emerging technology aids diabetic retinopathy screening
Address diabetic retinopathy by treating underlying disease
Laser still gold standard for diabetic retinopathy, although advances are in pipeline
Analysis weighs benefits of anti-VEGF therapy in proliferative diabetic retinopathy
Obstructive sleep apnea worsens diabetic retinopathy
PATIENT HANDOUT: Diabetic retinopathy

Click here to access these resources…

You are subscribed to ModernMedicine.com. To unsubscribe, click here

To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.